Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/7663
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSim, Thomas Soon Lip.en_US
dc.contributor.authorChan, Tiang Lee.en_US
dc.contributor.authorTeng, Alan Seng Kee.en_US
dc.date.accessioned2008-09-18T07:49:19Z-
dc.date.available2008-09-18T07:49:19Z-
dc.date.copyright2004en_US
dc.date.issued2004-
dc.identifier.urihttp://hdl.handle.net/10356/7663-
dc.description.abstractThis thesis has examined five significant mergers in the late 1990s and early 2000. The conclusion is that the financial performances of the merged entity actually show improvement but these mergers did not address the fundamental problem of the pharmaceutical industry; i.e., diminishing new product pipeline and rising research and development costs.en_US
dc.rightsNanyang Technological Universityen_US
dc.subjectDRNTU::Business::Finance::Mergers and acquisitions-
dc.titleMergers and acquisitions in the pharmaceutical industry: a case study.en_US
dc.typeThesisen_US
dc.contributor.supervisorBoyd, Robert Stewarten_US
dc.contributor.schoolNanyang Business Schoolen_US
dc.description.degreeMaster of Business Administrationen_US
item.grantfulltextrestricted-
item.fulltextWith Fulltext-
Appears in Collections:NBS Theses
Files in This Item:
File Description SizeFormat 
NBS-THESES_577.pdf
  Restricted Access		16.42 MBAdobe PDFView/Open

Page view(s)

497
Updated on Apr 18, 2025

Download(s)

3
Updated on Apr 18, 2025

Google ScholarTM

Check

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.